“Pleiotypic Response”
Avram Hershko(Rappaport Family Institute for Research in the Medical Sciences), Gordon M. Tomkins(University of California, San Francisco), Pierre S. Mamont, Robert L. Shields(Merck & Co., Inc., Rahway, NJ, USA (United States))
Cited by 423
Related Papers
THE UBIQUITIN SYSTEM
|Annual Review of Biochemistry|1998|8.8k
SKP2 is required for ubiquitin-mediated degradation of the CDK inhibitor p27
|Nature Cell Biology|1999|1.5k
High Resolution Mapping of the Binding Site on Human IgG1 for FcγRI, FcγRII, FcγRIII, and FcRn and Design of IgG1 Variants with Improved Binding to the FcγR
|Journal of Biological Chemistry|2001|1.2k
Components of ubiquitin-protein ligase system. Resolution, affinity purification, and role in protein breakdown.
|Journal of Biological Chemistry|1983|1.1k
The cyclosome, a large complex containing cyclin-selective ubiquitin ligase activity, targets cyclins for destruction at the end of mitosis.
|Molecular Biology of the Cell|1995|755